The Global Fund, in collaboration with a wide range of stakeholders, has embarked on the development of a Global Fund Investment Guidance for EECA for the 2014-2016 allocation period. The aim of this guidance is to recommend strategic priorities for contributing to sustainable impact on HIV/AIDS and TB in the region and thereby help reverse the tide of the epidemics.

A tuberculosis (TB) drug with a questionable safety profile increased the rate of sputum culture conversion in people with multidrug-resistant (MDR) disease, researchers reported.

A UCLA-led study has identified a protein that appears to play a key role in protecting people infected with Mycobacterium tuberculosis — the bacterium that causes tuberculosis — from developing the active form of the disease. The protein, interleukin-32, was discovered to be one biomarker of adequate host defense against TB.

UCLA-led research finds that a variant of an existing vaccine offers stronger protection against both diseases

BEIRUT: Foreign workers will now be subject to annual health tests due to the high prevalence of tuberculosis among migrant workers and Syrian refugees, said a memo issued by Labor Minister Sejaan Azzi Monday.

Exclusive worldwide license from Novartis includes a novel class of drugs that is active against drug sensitive and multi-resistant strains of tuberculosis.

Recently, Oxana Rucsineanu, a member of the TB Europe Coalition Steering Committee, was invited to take part in the WHO Review of the National TB Programme for TB Control in Armenia. Oxana’s invite follows calls from civil society organisations towards the WHO to include a civil society or key affected voice in these NTP reviews. With her extensive experience both of TB itself and of the need to include the civil society voice in TB programmes, Oxana was well placed to take part in this visit to Armenia. Here Oxana shares some of her findings and recommendations from the visit.

The HIV Online Provider Education (HOPE) program and Harvard University Center for AIDS Research present a HOPE physicians conference: Point-of-care diagnostics for HIV and tuberculosis in resource-limited settings.

The Global Fund should examine its position on policies and practices shown to have negative impacts on human rights, including “100% condom use” programs, the detention of TB patients, the use of drug registries, limitation of services for active drug users, forced sterilization, and use of condoms as evidence in court cases.

Civil society groups are receiving technical assistance paid for by the Global Fund to help focus the concept note on prevention activities targeting key populations